Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
2002 1
2003 2
2004 6
2005 3
2006 4
2007 5
2008 2
2009 3
2010 5
2011 24
2012 12
2013 5
2014 9
2015 12
2016 9
2017 3
2018 2
2019 6
2020 6
2021 6
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Cannon CP, et al. N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3. N Engl J Med. 2015. PMID: 26039521 Free article. Clinical Trial.
RESULTS: The median time-weighted average LDL cholesterol level during the study was 53.7 mg per deciliter (1.4 mmol per liter) in the simvastatin-ezetimibe group, as compared with 69.5 mg per deciliter (1.8 mmol per liter) in the simvastatin-monotherapy group (P<0.001) …
RESULTS: The median time-weighted average LDL cholesterol level during the study was 53.7 mg per deciliter (1.4 mmol per liter) in the simva …
Rivaroxaban in patients with a recent acute coronary syndrome.
Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators. Mega JL, et al. N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13. N Engl J Med. 2012. PMID: 22077192 Free article. Clinical Trial.
The twice-daily 2.5-mg dose of rivaroxaban reduced the rates of death from cardiovascular causes (2.7% vs. 4.1%, P=0.002) and from any cause (2.9% vs. 4.5%, P=0.002), a survival benefit that was not seen with the twice-daily 5-mg dose. As compared with placebo, riva …
The twice-daily 2.5-mg dose of rivaroxaban reduced the rates of death from cardiovascular causes (2.7% vs. 4.1%, P=0.002) and from an …
Long-term use of ticagrelor in patients with prior myocardial infarction.
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators. Bonaca MP, et al. N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14. N Engl J Med. 2015. PMID: 25773268 Free article. Clinical Trial.
RESULTS: The two ticagrelor doses each reduced, as compared with placebo, the rate of the primary efficacy end point, with Kaplan-Meier rates at 3 years of 7.85% in the group that received 90 mg of ticagrelor twice daily, 7.77% in the group that received 60 mg of ticagrelor twice …
RESULTS: The two ticagrelor doses each reduced, as compared with placebo, the rate of the primary efficacy end point, with Kaplan-Meier rate …
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
Abdel-Aziz MI, Vijverberg SJH, Neerincx AH, Brinkman P, Wagener AH, Riley JH, Sousa AR, Bates S, Wagers SS, De Meulder B, Auffray C, Wheelock ÅM, Bansal AT, Caruso M, Chanez P, Uddin M, Corfield J, Horvath I, Krug N, Musial J, Sun K, Shaw DE, Sandström T, Montuschi P, Fowler SJ, Lutter R, Djukanovic R, Howarth P, Skipp P, Sanak M, Adcock IM, Chung KF, Sterk PJ, Kraneveld AD, Maitland-van der Zee AH; U-BIOPRED Study Group. Abdel-Aziz MI, et al. Eur Respir J. 2022 Jan 13;59(1):2102603. doi: 10.1183/13993003.02603-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34824056 Free article. No abstract available.
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Rydén L, Tokgözoğlu L, Wood D, De Bacquer D; EUROASPIRE V collaborators; Writing Committee; Scientific Steering/ Executive Committee; Coordinating centre; Diabetes centre; Data management centre; Statistical analysis centre; Central laboratory; Study centres, organisations, investigators and other research personnel (National Co-ordinators in each country are indicated by asterisk. De Backer G, et al. Atherosclerosis. 2019 Jun;285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014. Epub 2019 Apr 24. Atherosclerosis. 2019. PMID: 31054483
Adverse effects in homeopathy. A systematic review and meta-analysis of observational studies.
Stub T, Kristoffersen AE, Overvåg G, Jong MC, Musial F, Liu J. Stub T, et al. Explore (NY). 2022 Jan-Feb;18(1):114-128. doi: 10.1016/j.explore.2020.11.008. Epub 2020 Nov 28. Explore (NY). 2022. PMID: 33303386 Review.

The frequency of adverse effects for control versus homeopathy was statistically significant (P < 0.0001). Analysis of sub-groups indicated that, compared to homeopathy, the number of adverse effects was significantly higher for conventional medicine (P = 0.0001)

…

The frequency of adverse effects for control versus homeopathy was statistically significant (P < 0.0001). Analysis of sub-groups

…
Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease.
Tran BN, Maass M, Musial G, Stern ME, Gehlsen U, Steven P. Tran BN, et al. Ocul Surf. 2022 Jan;23:131-139. doi: 10.1016/j.jtos.2021.12.008. Epub 2021 Dec 16. Ocul Surf. 2022. PMID: 34922011 Free article.

RESULTS: CB1R and CB2R are present at the ocular surface, and desiccating stress increased CBR expressions (p < 0.05). After 10 days of DED induction, treated groups demonstrated a reduced CBR expression in the cornea, which was concurrent with improvements in the DED p

…

RESULTS: CB1R and CB2R are present at the ocular surface, and desiccating stress increased CBR expressions (p < 0.05). After 10 da

…
Simultaneous vertebral and subclavian artery stenting.
Maciejewski DR, Tekieli Ł, Machnik R, Kabłak-Ziembicka A, Przewłocki T, Paluszek P, Trystuła M, Musiał R, Dzierwa K, Pieniążek P. Maciejewski DR, et al. Postepy Kardiol Interwencyjnej. 2017;13(2):142-149. doi: 10.5114/pwki.2017.68052. Epub 2017 May 30. Postepy Kardiol Interwencyjnej. 2017. PMID: 28798785 Free PMC article.

The mean North American Symptomatic Carotid Endarterectomy Trial (NASCET) VA stenosis was reduced from 88.7 9.7% to 5.7 6.8% and SA stenosis from 80 12.2% to 11 12.3% (p < 0.01). No periprocedural death, stroke, myocardial infarction or transient ischemic attack occurre

…
The mean North American Symptomatic Carotid Endarterectomy Trial (NASCET) VA stenosis was reduced from 88.7 9.7% to 5.7 6.8% and SA stenosis …
Mindfulness-based stress reduction for integrative cancer care: a summary of evidence.
Musial F, Büssing A, Heusser P, Choi KE, Ostermann T. Musial F, et al. Forsch Komplementmed. 2011;18(4):192-202. doi: 10.1159/000330714. Epub 2011 Aug 8. Forsch Komplementmed. 2011. PMID: 21934319 Free article. Review.
Estimating the effect on QoL, a total of n = 248 patients out of 6 studies was included and the overall effect size was 0.29 (95% confidence interval (CI) 0.17-0.40; p 0.00005). Calculating the effect on mood, a total of n = 411 patients out of ten studies were included, a …
Estimating the effect on QoL, a total of n = 248 patients out of 6 studies was included and the overall effect size was 0.29 (95% confidence …
Does admission anaemia still predict mortality six years after myocardial infarction?
Tomaszuk-Kazberuk A, Bolińska S, Młodawska E, Łopatowska P, Sobkowicz B, Musiał W. Tomaszuk-Kazberuk A, et al. Kardiol Pol. 2014;72(6):488-93. doi: 10.5603/KP.a2014.0046. Epub 2014 Feb 14. Kardiol Pol. 2014. PMID: 24526561 Free article.

Admission haemoglobin concentration was significantly associated with age (r = -0.2663, p < 0.05), blood pressure (systolic blood pressure [SBP]: r = 0.1940, diastolic blood pressure [DBP]: r = 0.2023, p < 0.05), glucose concentration (r = -0.1218, p &l

…

Admission haemoglobin concentration was significantly associated with age (r = -0.2663, p < 0.05), blood pressure (systolic blood

…
116 results